<DOC>
	<DOCNO>NCT02191254</DOCNO>
	<brief_summary>Study assess efficacy tolerability Antistax® film-coated tablet patient chronic venous insufficiency ( CVI , Clinical condition , Etiology , Anatomic location , Pathophysiology ( CEAP ) Classification : Clinical Class 3 , 4a )</brief_summary>
	<brief_title>Efficacy Tolerability Antistax® Male Female Patients Suffering From Chronic Venous Insufficiency</brief_title>
	<detailed_description />
	<mesh_term>Venous Insufficiency</mesh_term>
	<criteria>Male female 18 year age old CVI , Clinical Class 3 ( oedema ) 4a ( mild skin change ascribe venous disease , e.g . pigmentation ) , accord CEAP classification Willing able give write informed consent prior participation study Concomitant diseases : Decompensated cardiac insufficiency Oedema due venous disease leg ( e.g. , latent cardiac insufficiency , renal insufficiency , lymphoedema , etc ) Peripheral arterial disease ( ankle/arm pressure index &lt; 0.9 ) Current acute phlebitis thrombosis Renal insufficiency ( serum creatinine &gt; 1.5 mg/dl ) Liver disease ( SGPT &gt; 3x upper limit normal ) Other disease : hyper hypocalcaemia , malignancy Anamnestic indication diabetic microangiopathy polyneuropathy Drug and/or alcohol abuse Severe climacteric complaint : change , initiation postmenopausal hormone replacement therapy within last 3 month Immobility Avalvulia KlippelTrénaunayWeberSyndrome ( Naevus varicosis osteohypertrophicus , Haemangiectasia hypertrophicans ) State pulmonary embolism Recognised hypersensitivity trial drug ingredient Current florid venous ulcus Clinical indication necessary , specific phlebologic acute treatment , e.g . compression treatment , phlebectomy , etc . Previous treatment : Patients compression therapy and/or wear support stocking optimally benefit measure Treatment venous drug within last 2 week prior intake study medication Changes unstable response treatment theophylline , diuretic , cardiac glycoside , ACE inhibitor , calcium antagonist , laxative within last 2 week prior intake study medication Concomitant treatment/nondrug therapy exclusion criterion : Other venous drug apart trial medication Venous surgery sclerotherapy within last 12 month leg use volumetry Extensive use laxatives Major surgery require full anaesthesia Other exclusion criterion : Previously study protocol Participation another clinical trial within previous 90 day present study Patient investigator , coinvestigator , study nurse study Pregnant nursing woman inadequate birth control method ( applies females childbearing potential ) Patients consider mentally ill well unable work limit work ability , unable ( partially able ) follow speak write explanation concern trial Patients bad general health state accord investigator 's judgement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>